NCT05839951 2025-11-12
STAR-T
Bayer
Completed
Clinical Trials
8 trialsNCT04260269 2024-12-12
CardioSwitch
Helsinki University Central Hospital
Enrolling by invitation
NCT06221423 2024-01-24
Fruquintinib Combined With TAS-102 in Refractory Metastatic Colorectal Cancer
Fudan University
Unknown
NCT06195111 2024-01-08
A Real-world Study of Trifluridine/Tipiracil Containing Regimen for the Treatment of Patients With mCRC (REFLECT Study)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting
NCT06102785 2023-10-26
Fruquintinib Combined With TAS102 for Advanced Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital
Recruiting
NCT06031376 2023-09-11
Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC
Hunan Cancer Hospital
Completed
NCT05869097 2023-05-22
Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer
Hunan Cancer Hospital
Completed
NCT04965870 2022-03-07
RETRO-TAS
Hellenic Study Group of Psychoneuroimmunology in Cancer
Completed